Literature DB >> 34976235

Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.

Michał Łodyga1, Piotr Eder2, Magdalena Gawron-Kiszka3, Agnieszka Dobrowolska2, Maciej Gonciarz4, Marek Hartleb3, Maria Kłopocka5, Ewa Małecka-Wojciesko6, Piotr Radwan7, Jarosław Reguła8,9, Edyta Zagórowicz8,9, Grażyna Rydzewska1,10.   

Abstract

This paper is an update of the diagnostic and therapeutic recommendations of the National Consultant for Gastroenterology and the Polish Society of Gastroenterology from 2012. It contains 46 recommendations for the diagnosis and treatment, both pharmacological and surgical, of Crohn's disease in adults. The guidelines were developed by a group of experts appointed by the Polish Society of Gastroenterology and the National Consultant in the field of Gastroenterology. The methodology related to the GRADE methodology was used to assess the quality and strength of the available recommendations. The degree of expert support for the proposed statement, assessment of the quality of evidence and the strength of the recommendation was assessed on a 6-point Likert scale. Voting results, quality and strength ratings with comments are included with each statement.
Copyright © 2021 Termedia.

Entities:  

Keywords:  Crohn's disease; biological medicines; endoscopy; thiopurines

Year:  2021        PMID: 34976235      PMCID: PMC8690943          DOI: 10.5114/pg.2021.110914

Source DB:  PubMed          Journal:  Prz Gastroenterol        ISSN: 1895-5770


  300 in total

1.  Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.

Authors:  Zhuo Yang; Nick Clark; K T Park
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-21       Impact factor: 11.382

2.  ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update.

Authors:  Silvio Danese; Gionata Fiorino; Tim Raine; Marc Ferrante; Karen Kemp; Jaroslaw Kierkus; Peter L Lakatos; Gerassimos Mantzaris; Janneke van der Woude; Julian Panes; Laurent Peyrin-Biroulet
Journal:  J Crohns Colitis       Date:  2016-12-07       Impact factor: 9.071

3.  Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.

Authors:  Lior Katz; Javier P Gisbert; Beth Manoogian; Kirk Lin; Casper Steenholdt; Gerassimos J Mantzaris; Ashish Atreja; Yulia Ron; Arun Swaminath; Somal Shah; Ailsa Hart; Peter Laszlo Lakatos; Pierre Ellul; Eran Israeli; Mads Naundrup Svendsen; C Janneke van der Woude; Konstantinos H Katsanos; Laura Yun; Epameinondas V Tsianos; Torben Nathan; Maria Abreu; Iris Dotan; Bret Lashner; Jorn Brynskov; Jonathan P Terdiman; Peter D R Higgins; Maria Chaparro; Shomron Ben-Horin
Journal:  Inflamm Bowel Dis       Date:  2012-01-31       Impact factor: 5.325

4.  A Diagnostic Accuracy Meta-analysis of CT and MRI for the Evaluation of Small Bowel Crohn Disease.

Authors:  Wenhong Liu; Jincai Liu; Wenlian Xiao; Guanghua Luo
Journal:  Acad Radiol       Date:  2017-06-05       Impact factor: 3.173

Review 5.  Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.

Authors:  Morris Gordon; Khimara Naidoo; Adrian G Thomas; Anthony K Akobeng
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

6.  Diagnostic delay in a French cohort of Crohn's disease patients.

Authors:  Stéphane Nahon; Pierre Lahmek; Bruno Lesgourgues; Cécile Poupardin; Stanislas Chaussade; Laurent Peyrin-Biroulet; Vered Abitbol
Journal:  J Crohns Colitis       Date:  2014-02-13       Impact factor: 9.071

7.  Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.

Authors:  Paul Rutgeerts; Christopher Gasink; Daphne Chan; Yinghua Lang; Paul Pollack; Jean-Frederic Colombel; Douglas C Wolf; Douglas Jacobstein; Jewel Johanns; Philippe Szapary; Omoniyi J Adedokun; Brian G Feagan; William J Sandborn
Journal:  Gastroenterology       Date:  2018-08-29       Impact factor: 22.682

8.  Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases.

Authors:  Brona Wynne; Louise McHugh; Wei Gao; Denise Keegan; Kathryn Byrne; Catherine Rowan; Karen Hartery; Clemens Kirschbaum; Glen Doherty; Garret Cullen; Barbara Dooley; Hugh E Mulcahy
Journal:  Gastroenterology       Date:  2018-11-16       Impact factor: 22.682

9.  The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN.

Authors:  Shahar Bar Yehuda; Rachel Axlerod; Ori Toker; Nir Zigman; Iris Goren; Vered Mourad; Natan Lederman; Nurit Cohen; Eran Matz; Doron Dushnitzky; Matan Gavish; Nirit Borovsky; Doron Schwarts; Iris Dotan; Dan Turner
Journal:  J Crohns Colitis       Date:  2019-03-26       Impact factor: 9.071

10.  Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009).

Authors:  Vivek Chhaya; Sonia Saxena; Elizabeth Cecil; Venkataraman Subramanian; Vasa Curcin; Azeem Majeed; Richard C G Pollok
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

View more
  1 in total

1.  Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease.

Authors:  Edyta Maria Tulewicz-Marti; Konrad Lewandowski; Grażyna Rydzewska
Journal:  J Clin Med       Date:  2022-07-16       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.